{
    "info": {
        "nct_id": "NCT06105021",
        "official_title": "Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor",
        "inclusion_criteria": "1. Confirmed KRAS G12V mutational status and HLA-A*11:01 allele\n2. Histologically confirmed advanced or metastatic, unresectable solid tumor\n3. Progressed on or intolerant of at least one prior line of standard systemic therapy for the current malignancy.\n4. Measurable disease per RECIST v1.1.\n5. ECOG performance status 0-1\n6. Adequate organ and bone marrow function\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Any systemic cytotoxic chemotherapy, investigational agents, or any anti-tumor drug from a previous treatment regimen or clinical study (including small molecules and I/O compounds) within 5 half-lives or 14 days of Screening, whichever is shorter.\n2. Any prior gene therapy utilizing an integrating vector\n3. Previous allogeneic stem cell transplantation or prior organ transplantation\n4. History of treated primary immunodeficiency, autoimmune, or inflammatory disease including inflammatory bowel disease, systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, or Grave's disease\n5. Primary brain tumor\n6. Untreated central nervous system (CNS) metastatic disease, leptomeningeal disease, or cord compression.\n7. Uncontrolled active bacterial, viral, fungal, or mycobacterial infection\n8. Pregnant or lactating subjects\n9. Surgery or catheter-based interventions\n10. Previously identified allergy, hypersensitivity, or known contraindication to cyclophosphamide, fludarabine, or any other agent associated with lymphodepleting chemotherapy (LDC) or AFNT-211 product\n11. Uncontrolled significant intercurrent or recent illness\n12. Diagnosis of another malignancy within 2 years prior to screening.\n13. Seropositive for hepatitis B surface antigen (HBsAg) and/or hepatitis B core antibody (HBcAb)\n14. Seropositive for hepatitis C antibody.\n15. Known human immunodeficiency virus (HIV) infection",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "4. Measurable disease per RECIST v1.1.",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease per RECIST v1.1.",
                    "criterion": "disease measurability",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "key"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. ECOG performance status 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Adequate organ and bone marrow function",
            "criterions": [
                {
                    "exact_snippets": "Adequate organ ... function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... bone marrow function",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Progressed on or intolerant of at least one prior line of standard systemic therapy for the current malignancy.",
            "criterions": [
                {
                    "exact_snippets": "Progressed on ... at least one prior line of standard systemic therapy for the current malignancy",
                    "criterion": "response to prior standard systemic therapy",
                    "requirements": [
                        {
                            "requirement_type": "progression",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lines"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "intolerant of at least one prior line of standard systemic therapy for the current malignancy",
                    "criterion": "tolerance to prior standard systemic therapy",
                    "requirements": [
                        {
                            "requirement_type": "intolerance",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lines"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Confirmed KRAS G12V mutational status and HLA-A*11:01 allele",
            "criterions": [
                {
                    "exact_snippets": "Confirmed KRAS G12V mutational status",
                    "criterion": "KRAS G12V mutational status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "HLA-A*11:01 allele",
                    "criterion": "HLA-A*11:01 allele",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histologically confirmed advanced or metastatic, unresectable solid tumor",
            "criterions": [
                {
                    "exact_snippets": "Histologically confirmed",
                    "criterion": "diagnosis confirmation method",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": "histology"
                        }
                    ]
                },
                {
                    "exact_snippets": "advanced or metastatic, unresectable solid tumor",
                    "criterion": "tumor stage and resectability",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "advanced",
                                "metastatic"
                            ]
                        },
                        {
                            "requirement_type": "resectability",
                            "expected_value": "unresectable"
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "solid tumor"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "4. History of treated primary immunodeficiency, autoimmune, or inflammatory disease including inflammatory bowel disease, systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, or Grave's disease",
            "criterions": [
                {
                    "exact_snippets": "History of treated primary immunodeficiency",
                    "criterion": "primary immunodeficiency",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of treated ... autoimmune ... disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of treated ... inflammatory disease",
                    "criterion": "inflammatory disease",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including inflammatory bowel disease",
                    "criterion": "inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... systemic lupus erythematosus",
                    "criterion": "systemic lupus erythematosus",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... rheumatoid arthritis",
                    "criterion": "rheumatoid arthritis",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... myasthenia gravis",
                    "criterion": "myasthenia gravis",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including ... Grave's disease",
                    "criterion": "Grave's disease",
                    "requirements": [
                        {
                            "requirement_type": "history of treated disease",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Pregnant or lactating subjects",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... subjects",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating subjects",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "lactating",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Surgery or catheter-based interventions",
            "criterions": [
                {
                    "exact_snippets": "Surgery",
                    "criterion": "surgery",
                    "requirements": [
                        {
                            "requirement_type": "history or status",
                            "expected_value": "surgery"
                        }
                    ]
                },
                {
                    "exact_snippets": "catheter-based interventions",
                    "criterion": "catheter-based interventions",
                    "requirements": [
                        {
                            "requirement_type": "history or status",
                            "expected_value": "catheter-based intervention"
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. Seropositive for hepatitis C antibody.",
            "criterions": [
                {
                    "exact_snippets": "Seropositive for hepatitis C antibody.",
                    "criterion": "hepatitis C antibody serostatus",
                    "requirements": [
                        {
                            "requirement_type": "seropositivity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Diagnosis of another malignancy within 2 years prior to screening.",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of another malignancy within 2 years prior to screening.",
                    "criterion": "diagnosis of another malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Uncontrolled active bacterial, viral, fungal, or mycobacterial infection",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled active bacterial ... infection",
                    "criterion": "bacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled active ... viral ... infection",
                    "criterion": "viral infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled active ... fungal ... infection",
                    "criterion": "fungal infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled active ... mycobacterial infection",
                    "criterion": "mycobacterial infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "control_status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. Known human immunodeficiency virus (HIV) infection",
            "criterions": [
                {
                    "exact_snippets": "Known human immunodeficiency virus (HIV) infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "awareness/status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "Key"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "1. Any systemic cytotoxic chemotherapy, investigational agents, or any anti-tumor drug from a previous treatment regimen or clinical study (including small molecules and I/O compounds) within 5 half-lives or 14 days of Screening, whichever is shorter.",
            "criterions": []
        },
        {
            "line": "2. Any prior gene therapy utilizing an integrating vector",
            "criterions": []
        },
        {
            "line": "3. Previous allogeneic stem cell transplantation or prior organ transplantation",
            "criterions": []
        },
        {
            "line": "5. Primary brain tumor",
            "criterions": []
        },
        {
            "line": "13. Seropositive for hepatitis B surface antigen (HBsAg) and/or hepatitis B core antibody (HBcAb)",
            "criterions": []
        },
        {
            "line": "11. Uncontrolled significant intercurrent or recent illness",
            "criterions": []
        },
        {
            "line": "6. Untreated central nervous system (CNS) metastatic disease, leptomeningeal disease, or cord compression.",
            "criterions": []
        },
        {
            "line": "10. Previously identified allergy, hypersensitivity, or known contraindication to cyclophosphamide, fludarabine, or any other agent associated with lymphodepleting chemotherapy (LDC) or AFNT-211 product",
            "criterions": [
                {
                    "exact_snippets": "Previously identified allergy, hypersensitivity, or known contraindication to cyclophosphamide",
                    "criterion": "allergy to cyclophosphamide",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Previously identified allergy, hypersensitivity, or known contraindication to fludarabine",
                    "criterion": "allergy to fludarabine",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Previously identified allergy, hypersensitivity, or known contraindication to ... any other agent associated with lymphodepleting chemotherapy (LDC)",
                    "criterion": "allergy to any other agent associated with lymphodepleting chemotherapy (LDC)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Previously identified allergy, hypersensitivity, or known contraindication to ... AFNT-211 product",
                    "criterion": "allergy to AFNT-211 product",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}